3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
3
Uterine Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Myelodysplastic Syndromes
1
Muscle Invasive Bladder Cancer
1
Meningeal Carcinomatosis
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Cisplatin
13
pembrolizumab
10
Radiotherapy, Intensity-Modulated
9
Carboplatin
9
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Cetuximab
7
Radiotherapy
5
Radiation
5
Paclitaxel
5
Biopsy
5
Taxes
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Docetaxel
3
ipatasertib
2
durvalumab
2
X-Rays
2
Surgical Procedures, Operative
2
Standard of Care
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Disulfides
2
Chemoradiotherapy
2
trametinib
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
adavosertib
×
1 year
×
Clear all
No trials found.